Literature DB >> 34142886

A multiscale model of vascular function in chronic thromboembolic pulmonary hypertension.

Mitchel J Colebank1, M Umar Qureshi1, Sudarshan Rajagopal2, Richard A Krasuski3, Mette S Olufsen1.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by recurrent or unresolved pulmonary thromboemboli, leading to perfusion defects and increased arterial wave reflections. CTEPH treatment aims to reduce pulmonary arterial pressure and reestablish adequate lung perfusion, yet patients with distal lesions are inoperable by standard surgical intervention. Instead, these patients undergo balloon pulmonary angioplasty (BPA), a multisession, minimally invasive surgery that disrupts the thromboembolic material within the vessel lumen using a catheter balloon. However, there still lacks an integrative, holistic tool for identifying optimal target lesions for treatment. To address this insufficiency, we simulate CTEPH hemodynamics and BPA therapy using a multiscale fluid dynamics model. The large pulmonary arterial geometry is derived from a computed tomography (CT) image, whereas a fractal tree represents the small vessels. We model ring- and web-like lesions, common in CTEPH, and simulate normotensive conditions and four CTEPH disease scenarios; the latter includes both large artery lesions and vascular remodeling. BPA therapy is simulated by simultaneously reducing lesion severity in three locations. Our predictions mimic severe CTEPH, manifested by an increase in mean proximal pulmonary arterial pressure above 20 mmHg and prominent wave reflections. Both flow and pressure decrease in vessels distal to the lesions and increase in unobstructed vascular regions. We use the main pulmonary artery (MPA) pressure, a wave reflection index, and a measure of flow heterogeneity to select optimal target lesions for BPA. In summary, this study provides a multiscale, image-to-hemodynamics pipeline for BPA therapy planning for patients with inoperable CTEPH. NEW & NOTEWORTHY This article presents novel computational framework for predicting pulmonary hemodynamics in chronic thromboembolic pulmonary hypertension. The mathematical model is used to identify the optimal target lesions for balloon pulmonary angioplasty, combining simulated pulmonary artery pressure, wave intensity analysis, and a new quantitative metric of flow heterogeneity.

Entities:  

Keywords:  hemodynamics; mathematical modeling; pulmonary circulation; pulmonary hypertension; wave propagation

Mesh:

Year:  2021        PMID: 34142886      PMCID: PMC8410122          DOI: 10.1152/ajpheart.00086.2021

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   5.125


  63 in total

Review 1.  An image-based modeling framework for patient-specific computational hemodynamics.

Authors:  Luca Antiga; Marina Piccinelli; Lorenzo Botti; Bogdan Ene-Iordache; Andrea Remuzzi; David A Steinman
Journal:  Med Biol Eng Comput       Date:  2008-11-11       Impact factor: 2.602

2.  Pulmonary vascular morphology as an imaging biomarker in chronic thromboembolic pulmonary hypertension.

Authors:  F N Rahaghi; J C Ross; M Agarwal; G González; C E Come; A A Diaz; G Vegas-Sánchez-Ferrero; A Hunsaker; R San José Estépar; A B Waxman; G R Washko
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

3.  Morphometry of the human pulmonary vasculature.

Authors:  W Huang; R T Yen; M McLaurine; G Bledsoe
Journal:  J Appl Physiol (1985)       Date:  1996-11

4.  Pulmonary microvascular lesions regress in reperfused chronic thromboembolic pulmonary hypertension.

Authors:  David Boulate; Fréderic Perros; Peter Dorfmuller; Jennifer Arthur-Ataam; Julien Guihaire; Lilia Lamrani; Benoit Decante; Marc Humbert; Saadia Eddahibi; Philippe Dartevelle; Elie Fadel; Olaf Mercier
Journal:  J Heart Lung Transplant       Date:  2014-07-16       Impact factor: 10.247

5.  Characteristic impedance: frequency or time domain approach?

Authors:  M Umar Qureshi; Mitchel J Colebank; David A Schreier; Diana M Tabima; Mansoor A Haider; Naomi C Chesler; Mette S Olufsen
Journal:  Physiol Meas       Date:  2018-01-31       Impact factor: 2.833

6.  The Vascular Model Repository: A Public Resource of Medical Imaging Data and Blood Flow Simulation Results.

Authors:  Nathan M Wilson; Ana K Ortiz; Allison B Johnson
Journal:  J Med Device       Date:  2013-12-05       Impact factor: 0.582

Review 7.  Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and Mechanisms.

Authors:  Sarah Medrek; Zeenat Safdar
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

Review 8.  Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty.

Authors:  Timothy M Fernandes; David S Poch; William R Auger
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

Review 9.  An introduction to wave intensity analysis.

Authors:  Kim H Parker
Journal:  Med Biol Eng Comput       Date:  2009-02-11       Impact factor: 2.602

10.  Non-invasive procedural planning using computed tomography-derived fractional flow reserve.

Authors:  Michiel J Bom; Stefan P Schumacher; Roel S Driessen; Pepijn A van Diemen; Henk Everaars; Ruben W de Winter; Peter M van de Ven; Albert C van Rossum; Ralf W Sprengers; Niels J W Verouden; Alexander Nap; Maksymilian P Opolski; Jonathon A Leipsic; Ibrahim Danad; Charles A Taylor; Paul Knaapen
Journal:  Catheter Cardiovasc Interv       Date:  2020-08-26       Impact factor: 2.692

View more
  2 in total

Review 1.  Aerosol Transport Modeling: The Key Link Between Lung Infections of Individuals and Populations.

Authors:  Chantal Darquenne; Azadeh A T Borojeni; Mitchel J Colebank; M Gregory Forest; Balázs G Madas; Merryn Tawhai; Yi Jiang
Journal:  Front Physiol       Date:  2022-06-20       Impact factor: 4.755

2.  A computational model of contributors to pulmonary hypertensive disease: impacts of whole lung and focal disease distributions.

Authors:  Behdad Shaarbaf Ebrahimi; Merryn H Tawhai; Haribalan Kumar; Kelly S Burrowes; Eric A Hoffman; Margaret L Wilsher; David Milne; Alys R Clark
Journal:  Pulm Circ       Date:  2021-11-18       Impact factor: 2.886

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.